|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Director of Public Health
- NHS Trusts (England) - Chief Executive
- GP - Locum
- NHS 111 and Out of hours providers
- GP Practices
- DHSC Supply Disruption - Medicines
|
| Action category: |
|
Class 2: Action within 48 hours
|
| Title: |
|
CLASS 2 DRUG ALERT, ACTION WITHIN 48 HOURS, OTC CONCEPTS LTD, RELONCHEM LTD, NOUMED LIFE SCIENCES LTD AND MEDREICH PLC, RANITIDINE 75MG TABLETS (VARIOUS LIVERIES)
|
| Broadcast content: |
|
OTC Concepts Ltd, Relonchem Ltd and Noumed Life Sciences Ltd are recalling all unexpired stock of Ranitidine Tablets (various liveries) from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.
Medreich Plc is recalling specific batches of Ranitidine Tablets (various liveries) from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.
Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.
|
| Additional information: |
|
NHS England Regional Offices: Please cascade this alert to community pharmacies.
GP Practices: Please share this alert within your practice to assist the management of patients who use these medicines.
|
| Cascade to: |
|
- #GP#
- #COMMUNITYPHARMACISTS#
- #DISPENSING GP#
- #HospitalPharmacy#
|